Clinical Trials on LGMDR23 - LAMA2 Related

Total 51527 results

Ali Rezai
National Institute on Drug Abuse (NIDA)

Not yet recruiting

LIFU for Treatment for Refractory Opioid Use Disorder

Opioid Use Disorder
Drug Delivery Company, LLC DBA Akyso Pharmaceuticals
National Institute on Drug Abuse (NIDA); Laboratory Corporation of America; Cognitive...

Not yet recruiting

A Phase 1, Placebo-controlled, Single-Ascending-Dose, Study of BIOPIN 6 in Healthy Adults

Opioid Use Disorder
The University of Texas Health Science Center at...
National Institute on Drug Abuse (NIDA); Biomedical Development Corporation

Recruiting

KIOS Mobile App Evaluation

Opioid Use Disorder

United States
Yale University
National Institute on Drug Abuse (NIDA)

Not yet recruiting

Exploration of Synaptotrophic Effects of Psilocybin in Opioid Use Disorder (OUD)

Opioid Use Disorder

United States
University of Pennsylvania

Recruiting

Integrating Brain, Neurocognitive, and Computational Tools in OUD

Opioid Use Disorder

United States
Indivior Inc.

Recruiting

Evaluating the SUBLOCADE Treatment Exit Strategy

Opioid Use Disorder

United States, Canada
Indivior Inc.

Recruiting

SUBLOCADE Long-term Outcomes

Opioid Use Disorder

United States, Canada
Johns Hopkins University
National Institute on Drug Abuse (NIDA)

Recruiting

Piloting a Web Resource for Pregnancy OUD in Jail

Opioid Use Disorder

United States
Washington State University
National Institute on Drug Abuse (NIDA); University of Washington; Cherokee Nation...

Recruiting

Counseling for Harm Reduction and Retention in Medication-assisted Treatment - Cherokee Nation (CHaRRM-CN)

Opioid Use Disorder

United States
Montefiore Medical Center

Recruiting

Low-dose Buprenorphine Initiation for Opioid Use Disorder

Opioid Use Disorder

United States
New York State Psychiatric Institute
National Institute on Drug Abuse (NIDA)

Not yet recruiting

Sublingual Buprenorphine Through Telemedicine vs In-Person Care as Usual

Opioid Use Disorder
Washington University School of Medicine

Recruiting

Determining the Feasibility of Outpatient Parenteral Antibiotic Therapy for Persons Who Inject Opioids

Opioid Use Disorder

United States
Q2i, LLC
National Institute on Drug Abuse (NIDA); University of Massachusetts, Worcester

Recruiting

Reward-based Technology to Improve OUD Treatment (OARSCM)

Opioid Use Disorder

United States
VA Office of Research and Development

Recruiting

CRP and S&A for Inpatient Veterans (CRP and S&A)

Alcoholism | Dual Diagnosis | Substance-related Disorders

United States
Philadelphia College of Osteopathic Medicine
Patient-Centered Outcomes Research Institute; Boston University; University of... and other collaborators

Recruiting

Therapy and Peer Support for Patients Taking Medication for Opioid Use Disorder

Opioid Use Disorder

United States
University of British Columbia
Vancouver Coastal Health

Recruiting

Comparing Rapid Micro-Induction and Standard Induction of Buprenorphine/Naloxone for Treatment of Opioid Use Disorder

Opioid Use Disorder

Canada
Wayne State University

Not yet recruiting

Effects of Pharmacological Stress and rTMS on Executive Function in Opioid Use Disorder

Opioid Use Disorder

United States
University of California, Los Angeles

Recruiting

Patient Decision Aid for Opioid Use Disorder (PtDA-MAT)

Opioid Use Disorder

United States
Steve N. Caritis, MD
Eunice Kennedy Shriver National Institute of Child Health and Human Development...

Terminated

Pharmacologically-based Strategies for Opioid Substitution Therapy During Pregnancy

Pregnancy | Opiate Addiction

United States
University of Pittsburgh

Completed

Impact of Pregnancy on Buprenorphine Pharmacokinetics and Pharmacodynamics

Pregnancy | Opiate Addiction

United States
Brown University

Completed

Oxytocin, Stress, Craving, Opioid Use Disorder (OSCO)

Opioid Use Disorder

United States
Yale University
National Institute on Drug Abuse (NIDA)

Terminated

Neurofeedback in Individuals With Substance Use Disorders

Opioid-Related Disorders

United States
Wayne State University
NET Recovery Corp; Isaiah House

Active, not recruiting

NET Device for Treating Opioid Use Disorder

Opioid Use Disorder

United States
Sonara Health
Oregon Health and Science University; Stanford University; Adapt Oregon

Completed

Remotely Observed Methadone Evaluation (ROME)

Opioid Use Disorder

United States
New York State Psychiatric Institute
University of Kentucky

Completed

A Study to Evaluate the Abuse Potential of Oxymorphone Compared to Other Mu Opioid Agonists.

Opioid Use Disorder

United States
Cari Health Inc.
National Institute on Drug Abuse (NIDA); National Institutes of Health (NIH)

Completed

Assessment of Methadone and Buprenorphine in Interstitial Fluid

Opioid Use Disorder

United States
Pear Therapeutics, Inc.
National Institute on Drug Abuse (NIDA); Kaiser Foundation Research Institute; Whitman-Walker Institute, Inc... and other collaborators

Completed

Feasibility Study of Novel Prescription Digital Therapeutic Supporting Unobserved Buprenorphine Initiation & Adherence

Opioid Use Disorder

United States
Go Medical Industries Pty Ltd
National Institute on Drug Abuse (NIDA); Columbia University; New York State... and other collaborators

Completed

The O'Neil Long Acting Naltrexone Implant (OLANI) Pharmacokinetic (PK)/Safety Study in Healthy Volunteers

Opioid Use Disorder

United States
Trevi Therapeutics
Syneos Health

Completed

Oral Abuse Potential Study of Nalbuphine

Opioid Abuse | Nalbuphine

Canada
Braeburn Pharmaceuticals

Completed

Long-Term Safety Study of Buprenorphine (CAM2038) in Adult Outpatients With Opioid Use Disorder

Opioid Use Disorder

United States, United Kingdom, Taiwan, Hungary, Australia, Denmark, Germany, Sweden
Cambridge Health Alliance
Dartmouth College; MedicaSafe, Inc.; MySafeRx, Inc

Completed

MySafeRx & MedicaSafe Open-Label Buprenorphine Induction and Lapse Evaluation (MyMOBILE)

Opioid Use Disorder

United States
National Institute on Drug Abuse (NIDA)
University of Pennsylvania

Completed

Evaluation of Lofexidine for Treatment of Opioid Withdrawal - 3

Substance-Related Disorders | Opioid-Related Disorders

United States
National Institute on Drug Abuse (NIDA)
Cincinnati MDRU

Completed

Buprenorphine Dose Escalation Trial for Treatment of Non-Dependent Opiate Users - 2

Substance-Related Disorders | Opioid-Related Disorders

United States
National Institute on Drug Abuse (NIDA)
University of Texas

Completed

Naltrexone as Adjunct in Alcoholic Cocaine Dependent Patients - 4

Alcohol-Related Disorders | Cocaine-Related Disorders

United States
National Institute on Drug Abuse (NIDA)
University of Pennsylvania

Completed

Evaluation of Lofexidine for Treatment of Opioid Withdrawal - 7

Substance-Related Disorders | Opioid-Related Disorders

United States
National Institute on Drug Abuse (NIDA)

Unknown

Interactions Between Cocaine and Ethanol and Disulfiram - 1

Alcohol-Related Disorders | Cocaine-Related Disorders

United States
University of Chicago
National Institute on Drug Abuse (NIDA)

Completed

Effects of Subanesthetic Concentrations of Isoflurane/Nitrous Oxide - 3

Substance-Related Disorders | Opioid-Related Disorders

United States
University of Chicago
National Institute on Drug Abuse (NIDA)

Completed

Role of Instructions in Nitrous Oxide Effects and Choice - 10

Substance-Related Disorders | Opioid-Related Disorders

United States
University of Chicago
National Institute on Drug Abuse (NIDA)

Completed

Isoflurane at Subanesthetic Concentrations - 6

Substance-Related Disorders | Opioid-Related Disorders

United States
University of Chicago
National Institute on Drug Abuse (NIDA)

Completed

Effects of Nitrous Oxide: A Dose-Response Analysis - 5

Substance-Related Disorders | Opioid-Related Disorders

United States
UConn Health
National Institute on Alcohol Abuse and Alcoholism (NIAAA); National Institutes...

Completed

Pharmacokinetic Study of Single Dose Dutasteride in Healthy Subjects

Alcoholism | Alcohol Related Disorders | Alcohol Abuse

United States
University of Michigan
National Institute on Drug Abuse (NIDA)

Not yet recruiting

Adversity, Brain and Opioid Use Study

Healthy | Opioid Use Disorder

United States
University of Arkansas

Enrolling by invitation

Pharmacist-Led Interventions to Increase Access to Medications for Opioid Use Disorders (PLI-MOUD) (PLI-MOUD)

Opioid Use Disorder | Overdose

United States
University of North Carolina, Chapel Hill

Completed

Oxytocin Treatment of Opioid Dependence

Opioid Dependence | Opioid Withdrawal

United States
New York State Psychiatric Institute
National Institute on Drug Abuse (NIDA)

Completed

Memantine as a Supplement to Naltrexone in Treating Heroin Dependence (NAMHS)

Heroin Dependence | Opioid Dependence

United States
National Institute on Alcohol Abuse and Alcoholism...
University of Pittsburgh

Completed

Drug Treatment for Alcoholics With Bipolar Disorder

Alcoholism | Bipolar Disorder

United States
New York State Psychiatric Institute
National Institute on Drug Abuse (NIDA)

Completed

Behavioral Naltrexone Therapy for Promoting Adherence to Oral Naltrexone vs Extended Release Injectable Depot Naltrexone (Depot-BNT)

Heroin Dependence | Opiate Dependence

United States
Johns Hopkins University
National Institute on Drug Abuse (NIDA)

Completed

A Within Subject Comparison of Opioid Withdrawal in Opioid Dependent Individuals

Opioid Dependence | Opioid Abuse

United States
National Institute on Drug Abuse (NIDA)
New York MDRU

Completed

Buprenorphine/Naloxone in the Treatment of Heroin Dependence - 14

Substance-Related Disorders | Opioid Dependence

United States
National Institute on Drug Abuse (NIDA)
University of Texas

Completed

Buprenorphine as a Treatment for Individuals Dependent on Analgesic Opioids

Opioid-Related Disorders

United States

Clinical Trials on LGMDR23 - LAMA2 Related

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Serbia

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations